Premier Alternatives

Gordian Biotechnology

Drug Discovery · San Francisco, CA · Founded 2018 · Privately Held (backing)

Developer of a gene therapy discovery platform designed to improve research for complex diseases related to aging. Gordian Biotechnology is based in San Francisco, CA and was founded in 2018. It was valued at $170 million at its early-stage round in Dec 2021, the last priced event on record. It has raised $60 million across 1 recorded round; the latest was a $1.5 million seed round in Apr 2020.

PMV mark · valuation
$170.0M
Oct 2026
Priced at
its early-stage round
Dec 2021
Total raised
$60.0M
Last round
Seed Round
Apr 2020

Gordian Biotechnology key facts

as of Oct 2026
  • Developer of a gene therapy discovery platform designed to improve research for complex diseases related to aging.
  • Gordian Biotechnology is valued at approximately $170.0M as of Oct 2026, set at its early-stage round, Dec 2021; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $60.0M across 1 recorded rounds; the latest was Seed Round ($1.5M) in Apr 2020.
  • Notable investors include Metaplanet Holdings, Founders Fund, StartX (US), K5 Global, Caffeinated Capital — 32 tracked in total.
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$170.0M

Valued at $170.0M at its early-stage round, Dec 2021. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Gordian Biotechnology with a free account
  • ·The complete investor list: 32 names
  • ·Watch Gordian Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Gordian Biotechnology funding rounds

1 rounds
Apr 2020Seed Round$1.5M▮
Full funding history →

Gordian Biotechnology valuation

Gordian Biotechnology was valued at $170 million at its early-stage round in Dec 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Gordian Biotechnology raised?

Gordian Biotechnology has raised $60 million in total; 1 of its rounds is on record. The largest on record was a $1.5 million seed round in Apr 2020.

Gordian Biotechnology investors

32 investors are on record for Gordian Biotechnology, including Metaplanet Holdings, Founders Fund, StartX (US) and K5 Global. By type, the record holds 11 venture capital firms and 1 family office. The seed round in Apr 2020 drew 11 investors.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Cambrian Bio ($180 million), Claris Bio ($163 million) and Delix Therapeutics ($156 million).

About Gordian Biotechnology

Developer of a gene therapy discovery platform designed to improve research for complex diseases related to aging. The company's platform researches and develops therapeutic drugs that can prevent premature aging in humans, enabling doctors to cure age-related diseases and patients to improve their skin conditions.

Industry
Drug Discovery
Sector
Healthcare
HQ
San Francisco, CA, United States
Founded
2018
Employees
39
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.